Product

Showing 57–64 of 319 results

  • Chlortetracycline ELISA Test Kit

    Food Safety

    Chlortetracycline ELISA Test Kit is a competitive enzyme immunoassay for the quantitative analysis of Chlortetracycline in in honey, butter, fermented milk, feed, egg, cheese, milk, meat, meat products (sausage), fish and shrimp.

  • Chromogenic Endotoxin Test Kit

    Food Safety

    Endotoxins are complex lipopolysaccharides (LPS) , which are biologically activestructural components of the outer cell membrane of gram-negative bacteria with a molecular weight of around 10 kDa and their general structure consists of three parts: a lipid component containing fatty acids and disaccharide phosphates (Lipid A), O-specific polysaccharide side chains (Oligo S) and a core polysaccharide chain (O Poly S). Removal of endotoxin in biological product is one of the key criteria. Monitor and quantitatively measure the endotoxin level is required. The mainstream LAL method is time-consuming and lack a broad linear response range. REAGEN endotoxin fluorescent kit is a quick and accurate assay to quantitate the endotoxin level in a biological product.

  • Ciprofloxacin ELISA Test Kit

    Food Safety

    Ciprofloxacin ELISA Test Kit provides a competitive enzyme mmunoassay for the quantitative analysis of Ciprofloxacin in honey,fish,shrimp,meat,tissue,milk,serum and urine.

  • Ciprofloxacin-bsa

    Antibody Antigen
  • Clenbuterol ELISA Test Kit

    Food Safety

    Clenbuterol ELISA Test Kit is a competitive enzyme immunoassay for the quantitative analysis of clenbuterol in feed, liver, tissue and urine. 

  • Cobimetinib

    Enzyme Inhibitor
  • Coliform Test Petrifilms

    Food Safety

    Coliform is aerobic and facultative anaerobic gram-negative non-bacillus that can ferment lactose, produce acid and gas under certain culture conditions, and are the most commonly used microbial detection items. The REAGEN Coliform Test Petrifilms is a pre-made, ready-to-use medium containing modified VRB medium, cold water-soluble absorbent gel, and chromogenic agent to enhance colony counting.This test petrifilms is suitable for the determination of coliform in all kinds of food and food raw materials.

  • Conotoxins(CTX)

    Drug Material

    Conotoxins, a diverse family of small peptides found in the venom of cone snails, have garnered significant attention in various fields due to their highly specific interactions with ion channels and receptors in the nervous system. These interactions make them valuable tools and potential therapeutic agents in a range of applications, including:
    1. Pain Management
    Conotoxins offer a promising alternative to traditional opioids, particularly in managing chronic and neuropathic pain.
    One conotoxin, ω-conotoxin MVIIA (Ziconotide or Prialt®), has already received FDA approval for the treatment of severe, chronic pain in patients unresponsive to other treatments. This conotoxin works by selectively blocking N-type calcium channels in the spinal cord, reducing neurotransmitter release and pain signal transmission.
    Research is also exploring α-conotoxin RgIA derivatives, such as RgIA4 (KCP-400), as potential analgesics for neuropathic pain, including that induced by chemotherapy.
    Other conotoxins are being investigated as potential treatments for pain related to neck and spinal surgery, offering a safer alternative to opioids with potentially fewer side effects.
    2. Neurological Disorders
    Conotoxins are potent tools for investigating neuroelectrophysiology, signal transduction, and neural circuits, providing a theoretical foundation for the treatment of neurological disorders.
    They have shown significant potential in treating neurodegenerative diseases like Alzheimer’s and Parkinson’s disease by selectively modulating inter-neuronal communication and enhancing synaptic function.
    Conantokins, a family of conotoxins, are being studied for their potential in managing epilepsy and protecting against ischemic brain injury (stroke).
    Inhibitors of norepinephrine transport, such as analogues of the conotoxin χ-MrIA, are being investigated as potential treatments for attention-deficit hyperactivity disorder and depression.